{"schema_version":"secwatch.filing_event.v1","accession":"0001096906-22-000353","form_type":"8-K","ticker":"AXIM","cik":"0001514946","company_name":"AXIM BIOTECHNOLOGIES, INC.","filed_at":"2022-02-16T23:59:59+00:00","discovered_at":"2026-05-14T18:04:06.815472+00:00","generated_at":"2026-06-27T07:29:33.415008+00:00","sec_items":["1.01","1.02","2.03","3.02","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"AXIM raises $1.825M in new debt; retires $1.11M GS Capital note","bullets":["Issued two $250K short-term notes (1.5% interest, due March 10, 2022); one repaid on Feb 14.","Issued seven convertible notes aggregate $1.325M at 3% interest, due 2032; conversion at 70% of avg two lowest closing prices.","One $25K convertible note was acquired by director Blake N. Schroeder.","Repaid GS Capital Partners note ($1.11M face) in full; accrued interest $21,876 paid via 173,390 restricted shares."],"urls":{"canonical":"https://secwatch.observer/filing/0001096906-22-000353","json":"https://secwatch.observer/filing/0001096906-22-000353.json","markdown":"https://secwatch.observer/filing/0001096906-22-000353.md","text":"https://secwatch.observer/filing/0001096906-22-000353.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622000353/0001096906-22-000353-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622000353/axim-20220210.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T07:29:33.415008+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}